Answer
The plasma half-life of larotrectinib in cancer patients taking VITRAKVI 100 mg twice daily is approximately 3 hours.
Sources for this answer
- Vitrakvi 25 mg hard capsulesBayer plc · emc · SmPC §5.2 Pharmacokinetic properties · Version 14Document updated
Sources checked